| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5601048 | Chest | 2017 | 20 Pages |
Abstract
COPD treatment initiation with tiotropium compared with LABA does not increase cardiovascular risk in the first year of treatment. The risk of pneumonia is higher with LABA, a likely effect of the inhaled corticosteroids present in many LABA inhalers used in real world clinical practice.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Samy PhD, Sophie MSc, Pierre MD,